🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

William K. Kelly

Thomas Jefferson University

ORCID: 0000-0003-2629-672X

Also affiliated with Thomas Jefferson University Hospital

NursingMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing”.

Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing

The Prostate(2019)10.1002/pros.23739
N/A
0.712DataRank · unranked
114 citations

Sarah E. Hegarty, Colette Hyatt, Erin O'Leary, John Garcia, Karen E. Knudsen +3 more

High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0225
N/A
0.554DataRank · unranked
18 citations

Marianna Zahurak, Adel Mandl, Nicole A. Metri, Aliya Lalji, Elisabeth I. Heath +18 more

External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer

Journal of Clinical Oncology(2023)10.1200/jco.22.02661
N/A
0.510DataRank · unranked
29 citations

Qian Yang, Akash Roy, Bin Luo, John C. Araujo, Christopher J. Logothetis +15 more

Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0306
N/A
0.470DataRank · unranked
22 citations

Shijia Zhu, Vijayakumar Jawalagatti, Marc Carceles-Cordon, Adam Ertel, Saioa Garcia‐Longarte +20 more

The Safety of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer: An Individual-Participant Data Meta-Analysis Based on 14 Randomized Clinical Trials

Cancers(2025)10.3390/cancers17172747
N/A
0.312DataRank · unranked
7 citations

Nikita Nikita, Swapnil Sharma, Scott W. Keith, Kevin Zarrabi, William K. Kelly +2 more

1833P Concurrent high-dose IV Vitamin C (IVC) and docetaxel for metastatic castrate-resistant prostate cancer (mCRPC): A randomized, placebo-controlled, double-blind phase II trial

Annals of Oncology(2023)10.1016/j.annonc.2023.09.2781
N/A
0DataRank · unranked
0 citations

M.L. Zahurek, Adel Mandl, Michelle A. Rudek, Elisabeth I. Heath, Catherine H. Marshall +13 more

Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles

Molecular Cancer Research(2025)10.1158/1541-7786.mcr-24-0903
N/A
0DataRank · unranked
4 citations

Camila A. Bach, Ricardo A. Santos, Cecilia E. Verrillo, Nicole M. Naranjo, Ishan Chaudhari +12 more

Use of GIP and GLP-1 receptor agonists in prostate cancer patients.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.5024
N/A
0DataRank · unranked
0 citations

Kevin Zarrabi, Nikita Nikita, William K. Kelly, Grace Lu‐Yao, Amy L. Shaver